Teams working to improve substance use screening in trauma centers and relieve symptoms of a connective tissue disease take home this year’s Blue Sky Awards.

The South Carolina Rare Disease Council hosted a symposium that gathered rare disease researchers and advocates to chart the path forward for improved care.

The annual PurpleStride walk raises money for pancreatic cancer research at Hollings Cancer Center.

Patrick Flume, M.D., was recently honored with the Cystic Fibrosis Foundation's 2024 Impact Award.

A new worldwide study finds the blood thinner apixaban to be successful in reducing stroke in patients with subclinical atrial fibrillation.

Physician-researcher Marc Chimowitz was recognized for his lifelong contributions to research mentorship by the American Stroke Association in February.

MUSC Health-Florence is one of four sites in the Southeast chosen for the Equitable Breakthroughs in Medicine Development Initiative.

Pioneering genetic screening program enrolls first 20,000 South Carolinians and provides roadmap to guide future screening efforts.

MUSC will be one of four sites exploring the genetic basis of Parkinson’s disease in the Black community.

MUSC researchers have developed a training curriculum for community health workers to improve cancer genetic screening among Black women.